Philip Morris International 8-K
PositiveGuidance raised
Currency alone lifts 2026 adjusted EPS guidance as IQOS leads continued smoke-free growth.
Filed 2026-09-08 09:46 ET
- 7.01 Regulation FD Disclosure
- 9.01 Financial Statements and Exhibits
Summary
Investor-conference presentation with updated 2026 and Q3 adjusted EPS guidance. PMI raised its 2026 adjusted diluted EPS forecast for currency only. The presentation also cited continued smoke-free growth, led by IQOS, alongside robust combustibles performance.
Key Figures
- Smoke-free trends: Japan consumer offtake recovery was in line with expectations, with October pricing confirmed; PMI cited strong multicategory growth in international markets, including VEEV and ZYN.
- U.S. ZYN: the range is expanding, with 3mg and 6mg dry variants transitioning to 20 pouches per can in Q4 2026.
- Favorable currency contributes $0.24 to 2026 adjusted diluted EPS guidance and $0.01 to Q3 guidance.
Guidance
| Metric | Period | Guidance | Prior | Direction |
|---|---|---|---|---|
| Adjusted diluted EPS, non-GAAP | FY2026 | $8.35-$8.50; 10.7%-12.7% growth | — | Raised for currency only |
| Adjusted diluted EPS excluding currency, non-GAAP | FY2026 | $8.11-$8.26; 7.5%-9.5% growth | — | — |
| Adjusted diluted EPS, non-GAAP | Q3 2026 | $2.29-$2.34 | — | — |
Investor Takeaways
- Watch Q3 adjusted diluted EPS against the forecast, alongside Japan offtake and the confirmed October pricing.
- Track the Q4 U.S. ZYN portfolio transition and whether smoke-free growth remains broad-based.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3